Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
Baxter
AstraZeneca
Mallinckrodt
Medtronic

Last Updated: November 20, 2019

DrugPatentWatch Database Preview

Clinigen Hlthcare Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for CLINIGEN HLTHCARE, and what generic alternatives to CLINIGEN HLTHCARE drugs are available?

CLINIGEN HLTHCARE has three approved drugs.

There is one US patent protecting CLINIGEN HLTHCARE drugs.

There are nineteen patent family members on CLINIGEN HLTHCARE drugs in sixteen countries.

Summary for Clinigen Hlthcare
International Patents:19
US Patents:1
Tradenames:3
Ingredients:3
NDAs:3

Drugs and US Patents for Clinigen Hlthcare

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Clinigen Hlthcare FOSCAVIR foscarnet sodium INJECTABLE;INJECTION 020068-001 Sep 27, 1991 RX Yes Yes   Start Trial   Start Trial
Clinigen Hlthcare ETHYOL amifostine INJECTABLE;INJECTION 020221-001 Dec 8, 1995 AP RX Yes Yes   Start Trial   Start Trial
Clinigen Hlthcare TOTECT dexrazoxane hydrochloride INJECTABLE;INJECTION 022025-001 Sep 6, 2007 RX Yes Yes 6,727,253   Start Trial   Start Trial
Clinigen Hlthcare ETHYOL amifostine INJECTABLE;INJECTION 020221-002 Sep 10, 1999 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Clinigen Hlthcare

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Clinigen Hlthcare ETHYOL amifostine INJECTABLE;INJECTION 020221-002 Sep 10, 1999 5,242,471   Start Trial
Clinigen Hlthcare ETHYOL amifostine INJECTABLE;INJECTION 020221-002 Sep 10, 1999 5,994,409   Start Trial
Clinigen Hlthcare ETHYOL amifostine INJECTABLE;INJECTION 020221-001 Dec 8, 1995 5,424,471   Start Trial
Clinigen Hlthcare FOSCAVIR foscarnet sodium INJECTABLE;INJECTION 020068-001 Sep 27, 1991 4,215,113   Start Trial
Clinigen Hlthcare ETHYOL amifostine INJECTABLE;INJECTION 020221-001 Dec 8, 1995 5,994,409   Start Trial
Clinigen Hlthcare FOSCAVIR foscarnet sodium INJECTABLE;INJECTION 020068-001 Sep 27, 1991 4,339,445   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for CLINIGEN HLTHCARE drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe For Injection 500 mg/vial ➤ Subscribe 2004-04-16
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Express Scripts
Mallinckrodt
Boehringer Ingelheim
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.